These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2459751)

  • 41. Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma.
    Bostwick DG; Srigley J; Grignon D; Maksem J; Humphrey P; van der Kwast TH; Bose D; Harrison J; Young RH
    Hum Pathol; 1993 Aug; 24(8):819-32. PubMed ID: 8375853
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prostatic neuroendocrine cells].
    Herrero M; Rodríguez A; Cejas H
    Rev Fac Cien Med Univ Nac Cordoba; 2002; 59(1):91-6. PubMed ID: 12934249
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Usefulness of immunoperoxidase staining with high-molecular-weight cytokeratin in the differential diagnosis of small-acinar lesions of the prostate gland.
    O'Malley FP; Grignon DJ; Shum DT
    Virchows Arch A Pathol Anat Histopathol; 1990; 417(3):191-6. PubMed ID: 1696762
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Benign mimickers of prostatic adenocarcinoma.
    Srigley JR
    Mod Pathol; 2004 Mar; 17(3):328-48. PubMed ID: 14976539
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nephrogenic adenoma of the prostatic urethra involving the prostate gland: a clinicopathologic and immunohistochemical study of eight cases.
    Malpica A; Ro JY; Troncoso P; Ordoñez NG; Amin MB; Ayala AG
    Hum Pathol; 1994 Apr; 25(4):390-5. PubMed ID: 7512941
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Histological variants of prostatic carcinoma and their significance.
    Humphrey PA
    Histopathology; 2012 Jan; 60(1):59-74. PubMed ID: 22212078
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pseudoneoplastic lesions of the prostate gland.
    Young RH
    Pathol Annu; 1988; 23 Pt 1():105-28. PubMed ID: 2455266
    [No Abstract]   [Full Text] [Related]  

  • 48. Nuclear volume estimates in prostatic atypical adenomatous hyperplasia.
    López-Beltrán A; Artacho-Pérula E; Luque-Barona RJ; Roldán-Villalobos R
    Anal Quant Cytol Histol; 2000 Dec; 22(6):438-44. PubMed ID: 11147297
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atypical small acinar proliferation in the prostate: clinical significance in 2006.
    Bostwick DG; Meiers I
    Arch Pathol Lab Med; 2006 Jul; 130(7):952-7. PubMed ID: 16831049
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pseudobenign prostate carcinomas: causes of false-negative biopsy results.
    Dema A; Tăban S; Lazăr E; Borda A; Lăzureanu C; Herman D; Mureşan A; Cornianu M; Anderco D; Loghin A
    Rom J Morphol Embryol; 2011; 52(3 Suppl):963-74. PubMed ID: 22119811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Postatrophic hyperplasia of the prostate gland: a detailed analysis of its morphology in needle biopsy specimens.
    Amin MB; Tamboli P; Varma M; Srigley JR
    Am J Surg Pathol; 1999 Aug; 23(8):925-31. PubMed ID: 10435562
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prostate pathology case study seminar.
    Montironi R; Alexander E; Bostwick DG
    Virchows Arch; 1997 Jan; 430(1):83-94. PubMed ID: 9037320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Variants of acinar adenocarcinoma of the prostate mimicking benign conditions.
    Humphrey PA
    Mod Pathol; 2018 Jan; 31(S1):S64-70. PubMed ID: 29297496
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atypical adenomatous hyperplasia (adenosis) of the prostate: development of a Bayesian belief network for its distinction from well-differentiated adenocarcinoma.
    Montironi R; Bartels PH; Hamilton PW; Thompson D
    Hum Pathol; 1996 Apr; 27(4):396-407. PubMed ID: 8617484
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Atypical adenomatous hyperplasia (adenosis) of the prostate: DNA ploidy analysis and immunophenotype.
    Lopez-Beltran A; Qian J; Montironi R; Luque RJ; Bostwick DG
    Int J Surg Pathol; 2005 Apr; 13(2):167-73. PubMed ID: 15864380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Verumontanum mucosal gland hyperplasia in prostatic needle biopsy specimens. A mimic of low grade prostatic adenocarcinoma.
    Gaudin PB; Wheeler TM; Epstein JI
    Am J Clin Pathol; 1995 Dec; 104(6):620-6. PubMed ID: 8526203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prostatic intraepithelial neoplasia (PIN): morphological clinical significance.
    Mostofi FK; Sesterhenn IA; Davis CJ
    Prostate Suppl; 1992; 4():71-7. PubMed ID: 1374179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neutral and acid mucins and eosinophil and argyrophil crystalloids in carcinoma and atypical adenomatous hyperplasia of the prostate.
    Luna-Moré S; Florez P; Ayala A; Diaz F; Santos A
    Pathol Res Pract; 1997; 193(4):291-8. PubMed ID: 9258955
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Simultaneous tumour-like, atypical basal cell hyperplasia and acinar adenocarcinoma of the prostate: a comparative morphological and genetic approach.
    Luebke AM; Schlomm T; Gunawan B; Bonkhoff H; Füzesi L; Erbersdobler A
    Virchows Arch; 2005 Mar; 446(3):338-41. PubMed ID: 15726402
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Basal cell hyperplasia of the prostate.
    Cleary KR; Choi HY; Ayala AG
    Am J Clin Pathol; 1983 Dec; 80(6):850-4. PubMed ID: 6195916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.